Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- June 16, 2025
published in
- Advances in respiratory medicine Journal